Atlas Trials

Refractory Acute Leukemia

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Acute Leukemia

RecordFirmDate
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT05029141)The First Affiliated Hospital of Soochow University2021-09-01
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105)City of Hope Medical Center2020-11-18
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (NCT03834961)Children's Oncology Group2019-10-25
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia (NCT03735875)M.D. Anderson Cancer Center2019-01-25
A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia (NCT01701375)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2012-09-01
Allo-Allo Tandem Bone Marrow Transplant (BMT) (NCT00984412)Hadassah Medical Organization2009-11-01
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias (NCT00410423)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2006-01-01

Track Refractory Acute Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.